register

News & Trends - MedTech & Diagnostics

Takeover bid for diagnostics company opposed

Health Industry Hub | April 27, 2023 |

MedTech & Diagnostics News: Australian diagnostics company has been dealt a blow as a decision against conducting proceedings has been made over a takeover bid.

In March, Australian Clinical Labs (ACL) announced its intention to make an offmarket takeover bid to acquire its larger rival Healius, but the pathology provider said there were “a number of deficiencies” contained within the offer.

The merger of ACL and Healius would create Australia’s largest pathology provider, knocking Sonic Healthcare off its perch, with a combined group of more than 171 laboratories and 3413 approved collection centres nationally.

The proposed deal meant Healius shareholders would receive 0.74 ACL shares for every Healius share they owned. However, the proposed offer included 25 conditions and required unconditional ACCC approval and a 90% minimum acceptance condition.

Healius majority shareholders Perpetual Investment Management and Tanarra Capital weren’t impressed by the deal. Perpetual, which holds a 12.4% interest in Healius, said the deal was “unattractive”.

John Wylie’s Tannara Capital, which holds a 7.8% interest in Healius, was in a similar position. He backed up Healius’ stance on the offer that it was “overly restrictive” and the offer spanned an “unusually long” time. The offer lasts for six months.

Healius informed its shareholders at the time that it had written to the Takeovers Panel to address the deficiencies in the offer. But the Takeovers Panel has now laid down its verdict, declining to conduct proceedings and will publish its findings shortly.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.